KIRhub 2.0
Sign inResearch Use Only

AKT3

Sign in to save this workspace

UniProt Q9Y243 · PDB · AlphaFold · Substrate: Crosstide · Clone: full-length

Top inhibitors

#DrugInhibitionResidualKISSGini
1Capivasertib98.5%1.5%96.480.644
2Netarsudil69.2%30.8%93.220.676
3Midostaurin39.9%60.1%78.640.500
4Leniolisib27.4%72.6%100.000.604
5Umbralisib25.9%74.1%98.740.670
6Selumetinib25.5%74.5%100.000.640
7Ponatinib21.2%78.8%78.230.534
8Tenalisib17.5%82.5%97.980.702
9Baricitinib16.7%83.3%97.990.616
10Ceritinib16.1%83.9%95.440.618
11Infigratinib13.5%86.5%98.240.710
12Apatinib13.3%86.7%97.730.704
13Paxalisib11.4%88.6%99.750.609
14Darovasertib11.2%88.8%96.990.719
15Pacritinib9.6%90.4%88.640.452
16Sunitinib9.6%90.4%91.730.524
17Acalabrutinib9.3%90.7%99.500.670
18Sorafenib8.8%91.2%96.720.776
19Pemigatinib8.6%91.4%98.230.718
20Mobocertinib8.6%91.4%97.220.757

Paralog block

No paralog group registered for this kinase.

EMT expression

  • Mesenchymal log2(TPM+1): 4.46
  • Epithelial log2(TPM+1): 1.87
  • Fold change: 2.59
  • Status: Upregulated

Selectivity landscape vs inhibition on AKT3

Each point is one of the 92 approved drugs; color = inhibition % on AKT3.

Mutation lollipop

Cancer-associated mutations plotted by residue position. Marker size + color scale with the number of distinct cancer reports.

Variants (2)

Mutation × cancer associations

MutationCancerOrganSource
E17Kmalignant_melanoma_skinSkinref
E17Kcarcinoma_lungLungref
E17Kmalignant_melanoma_NSSkinref
E17Kcarcinoma_prostateProstateref
E17Kcarcinoma_thyroidThyroidref
E17Kleiomyosarcoma_soft_tissueSoft Tissueref
E17Kcarcinoma_penisGenitourinary systemref
E17Kcarcinoma_kidneyKidneyref
E17KKIRC-USKidneyref
E17KLUSC-USLungref
E17KPBCA-DEPancreasref
E17KSKCM-USSkinref
E17KKIRCKidneyref
E17KLUSCLungref
E17KSKCMSkinref
G171Rglioma_central_nervous_systemBrain/CNSref

3D structure

Embedded NGL viewer pulls a representative PDB entry (or AlphaFold model if no experimental structure is registered). Heavy bundle — loaded only on demand.

Annotations

Sign in to read and post annotations.

Loading…